Journal of the American College of Cardiology
Volume 70, Issue 12, 19 September 2017, Pages 1510-1524
The Present and FutureState-of-the-Art ReviewChronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment
State-of-the-Art Review
Under an Elsevier user license
open archive
Central Illustration
Key Words
heart failure
heart transplantation
prognosis
sudden death
Trypanosoma cruzi
Abbreviations and Acronyms
BNP
B-type natriuretic peptide
ChD
Chagas disease
ChHD
Chagas heart disease or chagasic cardiomyopathy
HF
heart failure
HTx
heart transplantation
ICD
implantable cardioverter-defibrillator
LVEF
left ventricular ejection fraction
NSVT
nonsustained ventricular tachycardia
PCR
polymerase chain reaction
RV
right ventricle/ventricular
SCD
sudden cardiac death
SVT
sustained ventricular tachycardia
T. cruzi
Trypanosoma cruzi
Cited by (0)
Dr. Bocchi has received consulting fees from Servier and AstraZeneca; has received subsidized travel/hotel/registration fees from Servier; has received membership in steering committees for Servier and Novartis; has performed contracted research for Jansen and Bayer/Merck; and has received honoraria from Novartis. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
© 2017 by the American College of Cardiology Foundation. Published by Elsevier.